1147872-22-7Relevant articles and documents
5-LIPOXYGENASE ACTIVATING PROTEIN (FLAP) INHIBITOR
-
Page/Page column 83, 88, (2009/05/30)
Described herein are methods for the synthesis of 3-[5-(pyridin-2-ylmethoxy)-3-(2-methyl-2-propylthio)-1-[4-(2-methoxypyridin-5-yl)benzyl]-indol-2-yl]-2,2-dimethyl-propionic acid, pharmaceutically acceptable salts, pharmaceutically acceptable solvates the
5-Lipoxygenase-activating protein inhibitors: Development of 3-[3-tert-butylsulfanyl-1-[4-(6-methoxy-pyridin-3-yl)-benzyl] -5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid (AM103)
Hutchinson, John H.,Li, Yiwei,Arruda, Jeannie M.,Baccei, Christopher,Bain, Gretchen,Chapman, Charles,Correa, Lucia,Darlington, Janice,King, Christopher D.,Lee, Catherine,Lorrain, Dan,Prodanovich, Pat,Rong, Haojing,Santini, Angelina,Stock, Nicholas,Prasit, Peppi,Evans, Jilly F.
body text, p. 5803 - 5815 (2010/03/24)
The potent and selective 5-lipoxygenase-activating protein leukotriene synthesis inhibitor 3-[3-tert-butylsulfanyl-1-[4-(6-methoxy-pyridin-3-yl)- benzyl]-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethylpropionic acid (11j) is described. Lead optimizati